A retrospective study focusing on clinical predictive factors in 126 patients with oesophageal carcinoma

Anticancer Research

Volumn 24, Issue 3 B, 2004, Pages 1915-1920

  Dreilich, Martin ^a   Bergström, Stefan ^a   Wagenius, Gunnar ^a   Brattström, Daniel ^a   Bergqvist, Michael ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Oesophageal carcinoma; Predictive factors; Survival

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SMOKING HABIT; SWALLOWING; SWEDEN; TUMOR LOCALIZATION;

AGED; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 3242691678     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. National Board of Health and Welfare cfe: Cancer Incidence in Sweden 2000. In: 1-117, 2000.
2. Devesa SS, Blot WJ and Fraumeni JF Jr: Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83: 2049-2053, 1998.
3. Blot WJ and McLaughlin JK: The changing epidemiology of esophageal cancer. Semin Oncol 26: 2-8, 1999.
4. Caletti G, Fusaroli P and Bocus P: Endoscopic ultrasonography. Digestion 59: 509-529, 1998.
5. Kulling D, Feldman DR, Kay CL et al: Local staging of esophageal cancer using endoscopic magnetic resonance imaging: prospective comparison with endoscopic ultrasound. Endoscopy 30: 745-749, 1998.
6. Rankin SC, Taylor H, Cook GJ and Mason R: Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma. Clin Radiol 53: 659-665, 1998.
7. Forsell-Aronsson E, Kiellén E, Mattson S and Hellström M: Medical imaging for improved tumour characterization, delineation and treatment verification. Acta Oncol 41: 604-614, 2002.
8. Talback M, Stenbeck M, Rosen M et al: Cancer survival in Sweden 1960-1998-developments across four decades. Acta Oncol 42: 637-659, 2003.
9. Rankin S and Mason R: Staging of oesophageal carcinoma. Clin Radiol 46: 373-377, 1992.
10. Ask A, Albertsson M, Jarhult J and Cavallin-Stahl E: A systematic overview of radiation therapy effects in oesophageal cancer. Acta Oncol 42: 462-475, 2003.
11. Albertsson M: Chemoradiotherapy of esophageal cancer. Acta Oncol 41: 118-123, 2002.
12. Law SY, Fok M and Wong J: Pattern of recurrence after oesophageal resection for cancer: clinical implications. Br J Surg 83: 107-111, 1996.
13. John MJ, Flam MS, Mowry PA et al: Radiotherapy alone and chemoradiation for nonmetastatic esophageal carcinoma. A critical review of chemoradiation. Cancer 63: 2397-2403, 1989.
14. Clark P: Surgical resection with or without pre-operative chemotherapy in oesophageal cancer: an updated analysis of a randomised control trial conducted by the UK Medical Research Council Upper GI Tract Cancer Group. Proc Am Soc Clin Oncol 126: 2001.
15. Smith TJ, Ryan LM, Douglass HO Jr et al: Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 42: 269-276, 1998.
16. Sykes AJ, Burt PA, Slevin NJ et al: Radical radiotherapy for carcinoma of the oesophagus: an effective alternative to surgery. Radiother Oncol 48: 15-21, 1998.
17. Mejean A, Oudard S and Thiounn N: Prognostic factors of renal cell carcinoma. J Urol 169: 821-827, 2003.
18. Conroy T, Etienne PL, Adenis A et al: Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival. Ann Oncol 13: 721-729, 2002.
19. Hajian-Tilaki KO: Factors affecting the survival of patients with oesophageal carcinoma under radiotherapy in the north of Iran. Br J Cancer 85: 1671-1674, 2001.
20. Kinoshita Y, Endo M, Nakayama K and Sato H: Clinical evaluation of ten-year survival cases after operation for upper and mid-thoracic esophageal cancer. Int Surg 67: 153-161, 1982.
21. Shimada H, Kitabayashi H, Nabeya Y et al: Treatment response and prognosis of patients after recurrence of esophageal cancer. Surgery 133: 24-31, 2003.
22. Andreasson S and Graffman K: Prevention of alcohol problems in primary health care. Patients receptive to questions concerning alcohol and life style. Lakartidningen 99: 4252-4255, 2002.
23. Cederqvist C, Nielsen J, Berthelsen A and Hansen HS: Cancer of the oesophagus. II. Therapy and outcome. Acta Chir Scand 144: 233-240, 1978.
24. Slevin NJ and Stout R: Carcinoma of the oesophagus-a review of 108 cases treated by radical radiotherapy. Clin Radiol 40: 200-203, 1989.
25. Manshanden CG, Hulscher JB, Hovius M et al: Limited resection for carcinoma of the upper thoracic oesophagus is not a realistic option. Eur J Surg Oncol 26: 561-566, 2000.
26. Puhakka HJ and Aitsato K: Oesophageal carcinoma: endoscopic and clinical findings in 258 patients. J Laryngol Otol 102: 1137-1141, 1988.
27. Kudsk KA, Tolley EA, DeWitt RC et al: Preoperative albumin and surgical site identify surgical risk for major postoperative complications. J Parenter Enteral Nutr 27: 1-9, 2003.
28. Manegold C: The causes and prognostic significance of low hemoglobin levels in tumor patients. Strahlenther Onkol 174 Suppl 4: 17-19, 1998.
29. Jelkmann W: Pitfalls in the measurement of circulating vascular endothelial growth factor. Clin Chem 47: 617-623, 2001.
30. Uchida S, Shimada Y, Watanabe G et al: In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis. Br J Cancer 77: 1704-1709, 1998.
31. Salgado R, Benoy I, Bogers J et al: Platelets and vascular endothelial growth factor (VEGF): a morphological and functional study. Angiogenesis 4: 37-43, 2001.